Chemical Component Summary

NameN-{4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]pyridin-3-yl}-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide
IdentifiersN-[4-[(1R,3S,5S)-3-azanyl-5-methyl-cyclohexyl]pyridin-3-yl]-6-[2,6-bis(fluoranyl)phenyl]-5-fluoranyl-pyridine-2-carboxamide
FormulaC24 H23 F3 N4 O
Molecular Weight440.461
TypeNON-POLYMER
Isomeric SMILESC[C@H]1C[C@H](C[C@H](C1)N)c2ccncc2NC(=O)c3ccc(c(n3)c4c(cccc4F)F)F
InChIInChI=1S/C24H23F3N4O/c1-13-9-14(11-15(28)10-13)16-7-8-29-12-21(16)31-24(32)20-6-5-19(27)23(30-20)22-17(25)3-2-4-18(22)26/h2-8,12-15H,9-11,28H2,1H3,(H,31,32)/t13-,14+,15-/m0/s1
InChIKeyVRQXRVAKPDCRCI-ZNMIVQPWSA-N

Chemical Details

Formal Charge0
Atom Count55
Chiral Atom Count3
Bond Count58
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB14943 
NameLGH-447
Groups investigational
DescriptionLGH-447 is under investigation in clinical trial NCT02160951 (Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies).
SynonymsLGH-447
CAS number1210608-43-7

Related Resource References

Resource NameReference
Pharos CHEMBL3651966
PubChem 44814409
ChEMBL CHEMBL3651966